Cargando…
Systemic Treatments and Molecular Biomarkers for Perivascular Epithelioid Cell Tumors: A Single-institution Retrospective Analysis
Perivascular epithelioid cell tumors (PEComa) are a large family of mesenchymal neoplasms, with variable clinical course. Evidence regarding treatment of advanced PEComas is scarce, with only one FDA-approved treatment available. The goals of this study were to provide data regarding systemic treatm...
Autores principales: | Testa, Stefano, Bui, Nam Q., Ganjoo, Kristen N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335919/ https://www.ncbi.nlm.nih.gov/pubmed/37448552 http://dx.doi.org/10.1158/2767-9764.CRC-23-0139 |
Ejemplares similares
-
nab-Sirolimus for Patients With Malignant Perivascular Epithelioid Cell Tumors
por: Wagner, Andrew J., et al.
Publicado: (2021) -
Malignant Perivascular Epithelioid Cell Tumor of the Esophagus
por: Fassan, Matteo, et al.
Publicado: (2012) -
Perivascular Epithelioid Cell Tumor in the Stomach
por: Shin, Sun Ah, et al.
Publicado: (2017) -
Malignant perivascular epithelioid cell tumor of the uterus
por: Bleeker, Jonathan S., et al.
Publicado: (2012) -
Perivascular Epithelioid Cell Tumors (PEComas) of the Orbit
por: Paliogiannis, Panagiotis, et al.
Publicado: (2017)